菲沃泰(688371) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 104,965,754.87, representing a 12.97% increase compared to CNY 92,913,492.03 in the same period last year[4]. - Net profit attributable to shareholders was CNY 6,313,627.91, up 20.04% from CNY 5,259,774.40 year-on-year[4]. - The net profit after deducting non-recurring gains and losses surged by 183.29%, reaching CNY 3,568,906.31 compared to CNY 1,259,788.90 in the previous year[4]. - Operating profit for Q1 2025 was ¥7,339,544.60, representing a 37.4% increase from ¥5,339,694.66 in Q1 2024[17]. - The company reported a net profit of RMB 4,183,507.50 for the period, recovering from a loss of RMB 2,130,120.41 in the previous period[14]. - The company’s total comprehensive income for Q1 2025 was ¥6,313,386.40, compared to ¥5,250,995.52 in Q1 2024[18]. Cash Flow and Assets - The net cash flow from operating activities was CNY 33,623,356.39, a significant recovery from a negative cash flow of CNY -13,797,072.47 in the same period last year[4]. - Cash flow from operating activities for Q1 2025 was ¥33,623,356.39, a significant recovery from a negative cash flow of -¥13,797,072.47 in Q1 2024[20]. - Cash and cash equivalents at the end of Q1 2025 totaled ¥223,563,268.29, down from ¥249,365,094.31 at the end of Q1 2024[21]. - The company's cash and cash equivalents increased to RMB 223,974,465.68 from RMB 182,005,082.42, representing a growth of approximately 23%[12]. - Total assets at the end of the reporting period were CNY 2,010,050,555.33, a decrease of 0.77% from CNY 2,025,574,271.48 at the end of the previous year[5]. - As of March 31, 2025, the company's total assets amounted to RMB 2,010,050,555.33, a decrease from RMB 2,025,574,271.48 as of December 31, 2024[12]. Liabilities and Equity - The total current liabilities decreased to RMB 99,591,869.86 from RMB 122,680,316.13, a reduction of about 19%[14]. - The company's total equity attributable to shareholders rose to RMB 1,907,785,955.18 from RMB 1,900,547,548.83, indicating a slight increase[14]. Research and Development - R&D investment totaled CNY 19,366,231.25, accounting for 18.45% of operating revenue, down from 22.86% in the previous year[5]. - Research and development expenses for Q1 2025 were ¥19,366,231.25, a decrease of 8.2% from ¥21,237,594.64 in Q1 2024[17]. Shareholder Information - The company had a total of 8,533 common shareholders at the end of the reporting period[8]. - Favored Tech Corporation Limited held 62.16% of the shares, with a total of 208,533,334 shares[9]. - The company repurchased a total of 4,658,312 shares, accounting for 1.3886% of the total share capital, with a total expenditure of RMB 50,202,577.62[11]. Non-Recurring Gains - The company reported non-recurring gains of CNY 2,744,721.60 after tax, primarily from government subsidies and other non-operating income[6].